Albany Molecular Res (AMRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 12-2010 | 12-2009 | 12-2008 | 12-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -32,296 | -62,871 | -16,695 | 20,560 | 8,936 |
| Depreciation Amortization | 33,782 | 54,305 | 40,029 | 18,022 | 16,990 |
| Income taxes - deferred | -976 | -1,918 | -10,980 | 1,535 | 1,350 |
| Accounts receivable | 2,129 | -7,661 | 15,079 | -10,961 | 6,727 |
| Accounts payable and accrued liabilities | N/A | N/A | -2,097 | 1,409 | 356 |
| Other Working Capital | -9,671 | -5,537 | 19,300 | -16,096 | 3,002 |
| Other Operating Activity | 5,551 | 22,361 | -5,550 | 12,071 | -5,694 |
| Operating Cash Flow | $-1,481 | $-1,321 | $39,086 | $26,540 | $31,667 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10,837 | -12,648 | -15,722 | -24,290 | -16,698 |
| Net Acquisitions | N/A | -46,340 | -12 | -1,729 | -11,898 |
| Purchase Of Investment | -817 | -7,825 | -19,549 | -25,265 | -67,665 |
| Sale Of Investment | 16,044 | 21,756 | 16,191 | 60,262 | 86,476 |
| Purchase Sale Intangibles | -423 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -423 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $3,967 | $-45,057 | $-19,092 | $8,978 | $-9,785 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 9,405 | N/A |
| Debt Repayment | -7,370 | -270 | -260 | -9,643 | -4,554 |
| Common Stock Issued | 671 | 592 | 510 | 1,285 | 1,437 |
| Common Stock Repurchased | N/A | -10,000 | N/A | -19,717 | N/A |
| Other Financing Activity | -270 | 0 | 5 | 56 | 121 |
| Financing Cash Flow | $-6,969 | $-9,678 | $255 | $-18,614 | $-2,996 |
| Exchange Rate Effect | -1,280 | 850 | 304 | -2,010 | 496 |
| Beginning Cash Position | 25,747 | 80,953 | 60,400 | 45,506 | 26,124 |
| End Cash Position | 19,984 | 25,747 | 80,953 | 60,400 | 45,506 |
| Net Cash Flow | $-5,763 | $-55,206 | $20,553 | $14,894 | $19,382 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,481 | -1,321 | 39,086 | 26,540 | 31,667 |
| Capital Expenditure | -10,837 | -11,628 | -15,172 | -23,938 | -17,747 |
| Free Cash Flow | -12,318 | -12,949 | 23,914 | 2,602 | 13,920 |